ArticleFrontiers in oncology2018

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker.

Benoît Tessoulin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.